Company intelligence / Profile preview
ExoCan Healthcare Technologies
Pune, Indiaexocanhealthcare.com ↗
- Ownership
- Private
- Employees
- ~25
- Development stage
- Other
01
Overview
ExoCan is developing exosome-based therapeutics and diagnostics for cancer and regenerative medicine. The company has multiple technology platforms including a proprietary exosome discovery platform for clinical-grade production and DerPileXO for active cargo loading into exosomes.
- Therapeutic areas
- OncologyDermatology
- Modalities
- Exosome-based therapySmall moleculeNucleic acid therapy
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
AKS Clinic
Beyond the preview
Go deeper on ExoCan Healthcare Technologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ExoCan Healthcare Technologies.